Glenmark gets USFDA nod for anti-cholesterol drug
Glenmark has been granted final approval by the USFDA for Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg10-04-2017
10-04-2017
Press Release
Dear Sirs, Sub:- Glenmark Pharmaceuticals receives ANDA approval for Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record.10-04-2017
Updates
Sub: Change in designation of Director This is to inform you that Mr. Rajesh Desai has ceased to be an Executive Director of the Company due to superannuation with effect from close of working hours on March 31, 2017. Mr. Desai has been with Glenmark for over thirty-four years. During this period, he has been a significant contributor in shaping the growth and sustained success of the Company. Mr. Desai will continue to be on the Board...31-03-2017
Glenmark gets USFDA nod for Milnacipran Hydrochloride tablets
Glenmark Pharmaceuticals has received tentative approval from the USFDA for Milnacipran Hydrochloride tablets. Glenmark Pharmaceuticals Inc, USA, has been granted tentative approval by the United...31-03-2017
Press Release
Sub:- Glenmark Pharmaceuticals receives tentative ANDA approval for Milnacipran Hydrochloride Tablets, 12.5 mg, 25 mg, 50 mg and 100 mg With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record.31-03-2017
Press Release
Sub:- Glenmark Pharmaceuticals Reports Positive Results from a Phase 3 Trial of GSP 301, Mometasone/Olopatadine Fixed-Dose Combination Nasal Spray, in Seasonal Allergic Rhinitis With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record.30-03-2017
Glenmark gets USFDA nod for skin ointment
Glenmark gets USFDA's approval for ointment used for treatment of various skin conditions21-03-2017
Press Release
Sub:- Glenmark Pharmaceuticals receives ANDA approval for Clobetasol Propionate Ointment USP, 0.05% With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record.21-03-2017
Glenmark gets tentative nod from USFDA for Fingolimod capsules
Glenmark Pharmaceuticals USA has got tentative approval from the United States Food and Drug Administration (USFDA) for Fingolimod capsules. These capsules are used in the treatment of adult...20-03-2017
Glenmark's Ankleshwar Plant Gets Inspection Report From USFDA
Glenmark was clarifying to the stock exchanges over a news report which claimed that its Ankleshwar plant received observations from the USFDA during its inspection in December 2016.15-03-2017